Top Journalists
Top Outlets
Are you a Prowly user?
Log in here
Top Journalists
>
Laura Joszt
Laura Joszt
Vice President, Content/Contributor at
The American Journal of Managed Care
Contact this person
Email address
l*****@*******.com
Get email address
Influence score
38
Phone
(XXX) XXX-XXXX
Get mobile number
Location
United States
Languages
English
Covering topics
Health & Medicine
View more media outlets and journalists by signing up to AI PR
View latest data and reach out all from one place
Sign up to AI PR Toolkit
Recent Articles
ajmc.com
Oncologists Grapple With Sequencing, Access as Treatments Multiply
Oncologists Grapple With Sequencing, Access as Treatments Multiply
14 days ago
ajmc.com
IRA, 340B, Medicaid: The Policy Pressures on Community Oncology
IRA, 340B, Medicaid: The Policy Pressures on Community Oncology
17 days ago
ajmc.com
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
18 days ago
ajmc.com
Real-World Data Back Dupilumab's Long-Term Use in Pediatric AD
Real-World Data Back Dupilumab's Long-Term Use in Pediatric AD
21 days ago
ajmc.com
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
22 days ago
ajmc.com
AI, Imaging, and Smarter Screening Drive Early Lung Disease Detection
AI, Imaging, and Smarter Screening Drive Early Lung Disease Detection
28 days ago
ajmc.com
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
about 1 month ago
ajmc.com
Better Cardiovascular Health Tied to Lower Overactive Bladder Risk
Better Cardiovascular Health Tied to Lower Overactive Bladder Risk
about 1 month ago
ajmc.com
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
2 months ago
ajmc.com
ICER Draft Flags High Cost of New Hypertension Drug Class
ICER Draft Flags High Cost of New Hypertension Drug Class
2 months ago
ajmc.com
OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs
OCTOPUS Trial Aims to Speed Access to Rare Sarcoma Drugs
2 months ago